Patel Snehal 4
4 · Greenwich LifeSciences, Inc. · Filed Jan 14, 2026
Insider Transaction Report
Form 4
Patel Snehal
DirectorCEO and CFO10% Owner
Transactions
- Purchase
Common Stock
2026-01-12$27.54/sh+2,900$79,866→ 5,602,302 total
Signature
/s/ Snehal Patel|2026-01-14